欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0253/001
药品名称
POULVAC IB QX
活性成分
avian infectious bronchitis virus lyophylisated 105.0 EID50
剂型
Lyophilisate for suspension
上市许可持有人
ZOETIS
参考成员国 - 产品名称
France (FR)
POULVAC IB QX
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Poulvac IB QX
Belgium (BE)
Poulvac IB QX
Netherlands (NL)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Poulvac IB QX Lyophilisate for Suspension for Spray Vaccination
Austria (AT)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Poulvac IB QX, liofilizatas purškiamai suspensijai ruošti vištoms
Estonia (EE)
Poulvac IB QX
Hungary (HU)
Bulgaria (BG)
Cyprus (CY)
Czechia (CZ)
Romania (RO)
Slovakia (SK)
Slovenia (SI)
许可日期
2013/03/20
最近更新日期
2024/08/12
药物ATC编码
QI01AD07 avian infectious bronchitis virus
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full dossier - art 12.3 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
WS2257 _ Annex b_WS2257 _ Annex b
Date of last change:2023/02/20
Final PL
|
WS2257 _ eAF_WS2257 _ eaf_maldi_tof_poulvac_range_signed
Date of last change:2023/02/20
Final Product Information
|
poulvac-ibqx-spc-pl
Date of last change:2021/07/16
Final SPC
|
FR_V_0253_001_MR Poulvac IB QX RCP pour CTS
Date of last change:2013/09/18
PAR
|
Poulvac IB QX FR_V_0253_001_MR PuAR 30042013
Date of last change:2013/09/18
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase